GNAS and thyroid nodule: While the majority have elucidated the rise in calcitonin levels as a consequence of Gsα signaling disruption [13,14], the concomitant presence of one or more thyroid nodules further deepens the complexity of clinical management since data on the risk of MTC in patients with PHP are currently lacking.